Quantitative Xylazine Measurement in ED

Description

Quantitative Xylazine Measurement Among Non-Fatal Opioid Overdose (OD) Patients in the Emergency Department (ED)

Conditions

Opioid Overdose, Substance Use Disorders

Talk to us

Study Overview

On this page

Study Details

Study overview

Quantitative Xylazine Measurement Among Non-Fatal Opioid Overdose (OD) Patients in the Emergency Department (ED)

Quantitative Xylazine Measurement Among Non-Fatal Opioid Overdose Patients in the Emergency Department

Quantitative Xylazine Measurement in ED

Condition
Opioid Overdose
Intervention / Treatment

-

Contacts and Locations

Elmhurst

NYC Health + Hospitals/Elmhurst, Elmhurst, New York, United States, 11373

New York

Icahn School of Medicine, New York, New York, United States, 10029

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * ED patient
  • * Opioid OD (both NPS and non-NPS)
  • * Availability of waste blood specimens for analysis
  • * Availability of waste urine specimens for analysis

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Icahn School of Medicine at Mount Sinai,

Jennifer Love, MD, MS, PRINCIPAL_INVESTIGATOR, Icahn School of Medicine

Study Record Dates

2026-02-24